VE1 (BRAF V600E) immunohistochemistry in colorectal cancer: Validation, assessment of heterogeneity and clinicopathological associations in three colorectal cancer cohorts

被引：0
|
作者：
Schafroth, C. [1 ]
Galvan, J. A. [1 ]
Sokol, L. [1 ]
Rieger, G. [1 ]
Dawson, H. E. [1 ]
Koelzer, V. H. [1 ]
Langer, R. [1 ]
Lugli, A. [1 ]
Zlobec, I. [1 ]
机构：
[1] Univ Bern, Inst Pathol, CH-3012 Bern, Switzerland
来源：
VIRCHOWS ARCHIV | 2015年 / 467卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-16-001
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation
    Kwon, Jeong-Hwa
    Jeong, Byung-Kwan
    Yoon, Yong Sik
    Yu, Chang Sik
    Kim, Jihun
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (03) : 157 - 163
  • [2] VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer
    Schafroth, Christian
    Galvan, Jose A.
    Centeno, Irene
    Koelzer, Viktor H.
    Dawson, Heather E.
    Sokol, Lena
    Rieger, Gregor
    Berger, Martin D.
    Haedrich, Marion
    Rosenberg, Robert
    Nitsche, Ulrich
    Schnueriger, Beat
    Langer, Rupert
    Inderbitzin, Daniel
    Lugli, Alessandro
    Zlobec, Inti
    ONCOTARGET, 2015, 6 (39) : 41453 - 41463
  • [3] VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
    Sperveslage, Jan
    Gierke, Midea
    Capper, David
    Honegger, Juergen
    Sipos, Bence
    Beschorner, Rudi
    Schittenhelm, Jens
    ACTA NEUROPATHOLOGICA, 2013, 125 (06) : 911 - 912
  • [4] Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma
    Pearlstein, Michelle V.
    Zedek, Daniel C.
    Ollila, David W.
    Treece, Amanda
    Gulley, Margaret L.
    Groben, Pamela A.
    Thomas, Nancy E.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2014, 41 (09) : 724 - 732
  • [5] VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
    Jan Sperveslage
    Midea Gierke
    David Capper
    Jürgen Honegger
    Bence Sipos
    Rudi Beschorner
    Jens Schittenhelm
    Acta Neuropathologica, 2013, 125 : 911 - 912
  • [6] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    MODERN PATHOLOGY, 2014, 27 : 173A - 173A
  • [7] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    LABORATORY INVESTIGATION, 2014, 94 : 173A - 173A
  • [8] VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma
    Sajanti, Sara
    Sirnio, Palvi
    Vayrynen, Juha P.
    Tuomisto, Anne
    Klintrup, Kai
    Makela, Jyrki
    Ristimaki, Ari
    Makinen, Markus J.
    VIRCHOWS ARCHIV, 2014, 464 (06) : 637 - 643
  • [9] VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma
    Sara Sajanti
    Päivi Sirniö
    Juha P. Väyrynen
    Anne Tuomisto
    Kai Klintrup
    Jyrki Mäkelä
    Ari Ristimäki
    Markus J. Mäkinen
    Virchows Archiv, 2014, 464 : 637 - 643
  • [10] BRAF V600E: PROGNOSTIC MARKER IN COLORECTAL CANCER
    Plestina, S.
    Rako, I.
    Jakic-Razumovic, J.
    Katalinic, D.
    Sertic, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 86 - 86
12345